Company Overview of YD Global Life Science Co., Ltd.
YD Global Life Science Co., Ltd. develops natural medical supplies, synthetic drugs, and functional health foods primarily in South Korea. The company develops synthesized drugs, such as diabetic retinopathy, neuro-pathic pain treatment, and natural medical supplies that include atopic dermatitis treatment, arthritis medicine, and obesity medicine. It also provides functional health foods, such as arthritis improvement, bone health improvement, body fat improvement, cognitive ability improvement, etc. The company was founded in 2008 and is headquartered in Seongnam, South Korea.
#909, ChungAng innotech Intellectual Industry Center
Founded in 2008
82 2 576 9331
82 2 576 9334
Key Executives for YD Global Life Science Co., Ltd.
Similar Private Companies By Industry
|Chunggei Pharmaceutical Co.,Ltd.||Asia|
|ABL Bio, Inc.||Asia|
|AD Biotech. Co., Ltd.||Asia|
|Ajinomoto Genexine Co., Ltd.||Asia|
|Asan Pharmaceuticals Co., Ltd.||Asia|
Recent Private Companies Transactions
May 8, 2018
January 12, 2018
December 11, 2017
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|Tax Management Inc||United States|
|John F. Kennedy Center For The Performing Arts||United States|
|NYC2012, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact YD Global Life Science Co., Ltd., please visit www.bioyd.co.kr. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.